At Amarin, we are committed to acting with openness and transparency across all our interactions with healthcare professionals (HCPs), healthcare organizations (HCOs) patient organizations (POs) and members of the public to advance patient care.
We believe that working with HCPs, HCOs and POs is integral to improving the lives of millions of patients in Europe. They provide valuable insight as well as independent and expert knowledge in their respective fields. From research and development and clinical trials to sales and marketing work or medical education support, these interactions ensure that HCPs and other external stakeholders have access to appropriate information about our products in order to make decisions that are in the best interests of their patients.
Our interactions are guided by transparency to ensure trust and confidence in the Pharmaceutical Industry and we support disclosure of these relationships to demonstrate their integrity. Amarin are committed to working within the Association of the British Pharmaceutical Industry’s (ABPI) Code of Practice. To support this, our transparency disclosure of payments to HCPs; HCOs; POs and members of the public are published below.
• Health Professionals and Healthcare Organisations:
For transparency reports for Health Professional and Healthcare Organisations, see the Disclosure UK database hosted on the website of the ABPI, please click here.
• Patient Organisations, Members of the Public and journalists:
To view information on payments made to support the work of patient organisations, Members of the Public (including patients and journalists), please click here.
For information on our methodological approach for HCPs, HCOs, POs and MoP (including patients and journalists), please click here.
• Collaborative Working
At Amarin, we are dedicated to fostering strong partnerships with various organisations, particularly the NHS, to improve patient care.
Collaborative working, either enhances patient care or is for the benefit of patients or alternatively benefits the NHS and, as a minimum maintains patient care. It is the pooling of skills, experience and / or resources from all the parties involved with a shared commitment to successful delivery from everyone involved and each organisation must make a significant contribution.
Joint working is a form of collaborative working which is patient centered and always benefits patients.
To ensure full transparency a summary of all our collaborative working projects is published prior to commencing and we encourage our partners to do this on their websites. We update this information on the conclusion of the project.
To learn more about our collaborative working projects click here.
• Clinical Trials
We continue to share clinical trial results of all sponsored Phase I, Phase II, Phase III and Phase IV clinical trials of Amarin marketed products conducted anywhere in the world on www.clinicaltrials.gov. Amarin also seeks to publish study results through peer-reviewed journals and scientific conferences.